UNSPSC 51434940: Hydrochlorothiazide/lisinopril

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV400. This VA Drug Class (CV400) classifies this compound as belonging to the group ANTIHYPERTENSIVE COMBINATIONS.

UNSPSC 51434940 Hydrochlorothiazide/lisinopril is a Commodity code that covers pharmaceutical products for state and local government use, though the recent solicitation activity under this code shows a mismatch: the City of Tampa's Advanced Life Support Medications bid (No. 26-P-00188, IFB) solicited emergency response medications including Labetalol, Epinephrine, Adenosine, and Diltiazem for Tampa Fire Rescue, none of which are hydrochlorothiazide/lisinopril. The solicitation indicates that state and local procurement under pharmaceutical codes targets acute-care and emergency-response drug supplies with firm expiration-date requirements, delivery timelines, and warranty provisions rather than chronic-disease maintenance medications like the code's nominal product. The City of Tampa's Purchasing Department is the identified issuing body, representing municipal procurement for emergency services.

Activity under this code shows limited recent volume. The Tampa Fire Rescue opportunity, posted April 24, 2026 with a due date of April 8, 2026 (already closed), carried an estimated contract value of $40,000 and was open to Small Local Business Enterprises with a 5 percent bid discount not to exceed $10,000. The code shows no other recent state or local opportunities in the source data. The geographic location identified is Hillsborough County, Florida. Because the Tampa solicitation reflects acute-care emergency medications rather than the hydrochlorothiazide/lisinopril indicated by the code name, the code's relevance to chronic-disease pharmaceutical procurement remains unclear from current activity.